Showing 1 - 10 of 308
Persistent link: https://www.econbiz.de/10010257208
Persistent link: https://www.econbiz.de/10011552915
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012157261
Persistent link: https://www.econbiz.de/10013493053
Persistent link: https://www.econbiz.de/10000830528
Persistent link: https://www.econbiz.de/10000824795
Persistent link: https://www.econbiz.de/10000421795
Persistent link: https://www.econbiz.de/10000601917
Persistent link: https://www.econbiz.de/10003729378